(This content is being used for illustrative purposes only; any person depicted in the content is a model)
The opioid crisis has affected every community in America. Opioids affect rural working class people, those in the inner city and suburbs, or even the wealthy and well-to-do professionals. While drug abuse in business has been highlighted in blockbuster films like the Wolf of Wall Street, the current reality is not far from it. According to addiction experts, substance use disorder is making a sobering impact on the financial industry.
This comes from not just an upscale partying lifestyle, but also from drugs used to manage performance and stress, along with physical pain. According to addiction experts, the financial industry itself is actively turning a blind eye to the issues concerning opioid abuse on Wall Street because money is still the priority, and stigma still gets in the way.
Opioids on Wall Street: White-Collar Confessions
As it stands there is no comprehensive research that takes a detailed look at opioid abuse in Wall Street among finance professionals. So we can’t exactly show the numbers to prove it’s prevalence. However, what we see consistently is a dramatic increase in addiction and overdose rates all over the nation in recent years.
Luckily, professionals from this demographic are beginning to speak out in hopes of progressive change.
One such individual is Trey Laird, a former Wall Street trader, who recently spoke to CNBC about his six-year opioid addiction. During the conversation Laird reiterates the critical understanding that substance use disorder can reach anyone, saying:
“Addiction pervades every single socioeconomic demographic that there is. Every industry, every race, men, women. It doesn’t care who you are,”
After getting clean himself, Laird went on to open a sober living community and says he hopes to specifically serve the Wall Street and white collar demographic.
According to Laird, there has been more talk about opioid addiction among people in higher socioeconomic brackets, but there is still much work that needs to be done. He acknowledges that increasing awareness is doing a great deal, but that the problem is also at an increase. Wall Street may finally be talking about it, but how many professionals will get the help they truly need?
Opioids on Wall Street: Stocks and Stigma
One of the biggest obstacles facing white-collar workers like those in Wall Street is the engrained stigma still attached to addiction. Even with all the shifts in our culture toward a better understanding of substance use and the compassion for those struggling, professionals still have this seemingly unbearable hurdle in front of them.
Truthfully, stigma is something that prevents most people from getting help. Professionals will often be too afraid of losing their jobs to admit they need help. Many in the world of Wall Street and finance may have no information on how to seek out treatment while adhering to their professional boards’ guidelines and business practices.
With white-collar workers, this may be an especially difficult thing because the idea of addiction is so often attached to stereotypes of the unemployable, the homeless, the unreliable and unstable that their high-earning careers might minimize the impact drugs have on their lives. Wall Street stockbrokers and traders might not see themselves as having a problem as long as they can function, which brings in the idea of the “functioning addict.”
Opioids on Wall Street: Function Addiction is Still Addiction
Many white-collar workers who struggle with drugs or alcohol may consider themselves a “functioning addict”, meaning they are less likely see their actions as a problem because they are able to maintain their professional or even personal lives. To make matters worse, frequently the people around someone who is professionally successful will not believe the addiction is real. They may admit that you’ve been careless or destructive in some respects, but will ultimately minimize it due to your financial stability.
As long as you’re making money and paying the bills how could you possibly be “that bad?”
Well, because “functioning addiction” is still an addiction.
Addiction isn’t about whether or not you are able to hold down a steady income. It does not depend on whether or not other people recognize that you have a problem or your competence with your profession. While addiction can and will have an impact on these things, it isn’t always as black and white as most people like to pretend.
Notice how earlier we said you may “maintain” other areas of your life? Well, we mean to say that you can get by for a while, but eventually, the effects of addiction will catch up with you. It could be in the form of serious health consequences or other devastating circumstances. It could take days, months or even years, but it will leave a mark.
Sadly, “functioning addicts” are also far less likely to get the help they desperately need.
Opioids on Wall Street: It Could Be You
While you might be able to keep your addiction secret, in the beginning, things will eventually get worse. Eventually, your addiction will become unmanageable.
If you think you might fit the “functioning addiction” criteria, look at the following questions and answer them honestly.
- Do you often think about using drugs or drinking?
- Do you find it hard to stop after you start drinking or using?
- Are you scheduling your time around drinking or using drugs?
- Have you tried to stop before, but found that you were unable to?
- Do you drink or use drugs first thing in the morning?
- Are you drinking or using drugs at work?
- Do you hide your drug use or drinking?
- Have you done something risky, like driven drunk?
- Do you worry about your drug use or drinking?
If you find you are answering “yes” more than “no” then you should seriously consider speaking with a medical or addiction professional about your drug use or drinking.
The opioid crisis is nothing to be ignored. Despite all that we think we have learned about addiction too many professionals don’t get the help they need. No one is exempt from the destruction of addiction. Opioids don’t care what street you work on, Wall Street or not, they can ruin your life all the same. If you or someone you love is struggling, please call toll-free now. We want to help.
CALL NOW 1-888-922-5398
Before the hype around recreational use of marijuana in California could even begin to dwindle, new reports are stating that President Trump’s Attorney General Jeff Sessions is planning to begin a federal crackdown on marijuana laws.
Jeff Sessions is set to announce today that he is rescinding memos sent out from the Obama administration that established a policy of non-interference with state laws concerning marijuana use. For some time now there have been several stories highlighting Jeff Sessions’ disagreement with allowing states to decide their own laws concerning medical or recreational marijuana use. Some sources indicate he has been planning a new strategy that will actually bring federal law to a head against state marijuana policies.
UPDATE: According to The Washington Post, Jeff Sessions notes in a memo sent to U.S. attorneys that federal law prohibits the possession and sale of marijuana. Sessions undid four previous Obama administration memos that advised against bringing prosecutions in states where marijuana was legalized to use for recreational or medical purposes. Sessions said prosecutors should use their own discretion in weighing whether charges were appropriate.
So what does all this mean for marijuana states?
The Obama Era Policy
The memo essentially describing the Obama-era policy through the Justice Department is known as the “Cole Memo”. It was named after then-Deputy Attorney General Jim Cole in 2013.
The “Cole Memo” outlined new priorities for federal prosecutors in states legalized use of marijuana. These shifts in policy represented a major change from the strict enforcement approach of past administrations to an attitude of non-interference. Back in 2014 U.S. Congress approved legislation preventing the DEA from carrying out any raids, arrest, or prosecutions of patients using medical marijuana. Congress also blocked law enforcement agencies under the Justice Department from consuming federal dollars in efforts to enforce federal marijuana laws in states that have legalized the use of medicinal marijuana. Under President Barack Obama, the Department of Justice did not pursue action against states that legalized recreational marijuana use. In 2015 there was a bipartisan effort in Congress to block the DEA from using federal funding for aggressively pursuing marijuana in the states where it was legalized.
The Obama era outline essentially allowed states to decide whether or not to legalize marijuana and to what extent. The federal prosecutors would not intervene as long as the state regulations did not threaten other federal priorities. So the distribution of marijuana to minors and cartels was still prohibited.
So with this announcement, many are wondering if Jeff Sessions will be working to undo other changes as well.
The Jeff Sessions Reversal
At the time of writing this article, whether or not Jeff Sessions will offer up a new strategy for dealing with marijuana-friendly states or not has yet to be seen. At this time the great concern is how this announcement may end up putting state and federal law in conflict, and what to expect out of enforcement from the federal government.
But many say this is a frustrating development, especially considering that President Trump has said in the past that he would not allow his attorney general to change the current policy, telling a reporter that,
“I’m a states person. I think it should be up to the states, absolutely.”
If we go back to February of 2017, Sean Spicer suggested in a press conference that the Trump administration and the Justice Department already had the intentions to no longer turn a blind eye to states with their own legal marijuana laws. At the time Spicer said the Trump administration would be “taking action” against these states. Contradicting all the talk of states’ rights and rolling back federal enforcement.
Many are wondering if President Trump was consulted about this decision, or if he has been made aware of the implications of this change. Especially since it goes against his original campaign promise to leave marijuana laws to the states.
This move would lay the groundwork for the federal government to begin a crackdown on the rapidly increasing marijuana industry all across the country. If these reports are confirmed this afternoon with no new innovations in their place, this move could have a drastic impact on the economics around the marijuana industry.
Sessions Track Record
However, this should all come as no surprise, since Jeff Sessions has repeatedly spoken out against decriminalization of marijuana and a return to the failed tactics of the War on Drugs at every turn.
In fact, a key adviser on marijuana policy to Jeff Sessions, Dr. Robert DuPont, believes drug testing should be a routine part of primary-care medicine. He has gone as far to suggest that primary-care physicians should be given the power to force some patients into treatment against their will. DuPont also suggests the following treatment to subject individuals to monitoring and random drug tests for up to 5 years.
Dr. Robert DuPont was among a small group of drug-policy experts involved last month in a closed-door meeting with Sessions to discuss federal options for dealing with the rapid liberalization of state marijuana laws.
The Marijuana States
Eight states and the District of Columbia have laws allowing for personal consumption of marijuana for recreational purposes. 28 states and the District of Columbia have legalized marijuana for medical use. Even more states recently have begun to talk about changes in their own policies. California voters pushed through legislation to legalize recreational use back in November of 2017, and with the start of the New Year, those laws went into effect. Now, not even a week later, the fate of this state’s new policy is hanging in the balance.
Needless to say, marijuana advocates all over the nation are troubled by this news. According to NORML Political Director Justin Strekal,
“If the Trump administration goes through with a crackdown on states that have legalized marijuana, they will be taking billions of dollars away from regulated, state-sanctioned businesses and putting that money back into the hands of drug cartels,”
But some states are not ready to give up on their marijuana laws. Other Republicans, such as Colorado Senator Cory Gardner, are avidly speaking out in opposition to the recent decision by Jeff Sessions. Senator Gardner has vowed to prevent any new appointees for the Department of Justice from being confirmed until this reversal has been reversed.
Hopefully, when Jeff Sessions makes his official announcement, we will have some more clarity on how the federal government plans to address marijuana use going forward.
While the legal status of marijuana may soon be up for a serious debate, the fact remains that it is still possible to abuse marijuana. Whether a drug is legal or not, there are still risks. There are already plenty of legal drugs that cost thousands of lives every year. When substance use becomes habitual it can be extremely harmful to an individual who struggles with substance use disorder. Even though marijuana is not claiming lives like the opioid epidemic, for some it has adverse effects on the quality of life.
While marijuana is not considered to be as dangerous as other illicit drugs, such as heroin or methamphetamines, it can cause dependence for people who use the drug. The typical consensus that marijuana is not as physically destructive and addictive as other “harder” drugs doesn’t change the fact that psychiatrists also believe the psychological impacts of a substance do matter when talking about an addiction. These effects can be just as detrimental.
Marijuana addiction treatment offers a safe and secure environment while providing a variety of therapeutic opportunities to help develop a healthy lifestyle without relying on the use of marijuana or other drugs.
There still needs to be resources available to help people who suffer from abuse. Supporting addiction recovery means breaking the stigma and offering holistic and effective solutions. Palm Healthcare Company is here to help. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-888-922-5398
This past Wednesday, Attorney General Jeff Sessions made the announcement that White House counselor Kellyanne Conway will be the Trump administration’s go-to for opioid crisis efforts. This announcement has been met with both praise and criticism. Some say this appointment actually gives validity to the White House’s commitment to solving the ongoing opioid epidemic, while others see it as the exact opposite.
For a little background, Kellyanne Conway worked as a pollster before becoming Trump’s campaign manager during his run for the 2016 presidential nomination. Currently, Conway serves as a White House spokeswoman and Trump surrogate. She has been seen on countless panels discussing the biggest topics and politics. She absolutely has her work cut out for her, so can Kellyanne Conway compete?
The Kellyanne Cons and Pros
So can this infamous Trump advocate, the woman who practically accidentally coined the phrase “alternative facts” compete with the opioid crisis in America? Kallyanne Conway has become notorious for defending some of President Trump’s most flagrant and controversial “alternative facts” in the media. But in her defense, she also has said some things that seem to highlight important prospects for this problem.
So here are some things to consider when we talk about Kellyanne Conway being put in charge of the opioid epidemic.
Lack of Experience
One of the big problems with this appointment people are pointing out is the lack of experience. Critics say this appointment speaks to how little passion the current administration is actually putting into fighting the opioid crisis since Kellyanne Conway has no experience in public health or with drug policy.
But in a time where Americans seem to be putting more trust in people that don’t typically meet the description of “qualified” in hopes that an outsider might bring better results, it makes sense that a lot of people might still hope Kellyanne can do some good.
Yet, there are still those who aren’t so sure. Tom Synan, a police chief and member of the Hamilton County Heroin Coalition in Ohio tweeted in response to the announcement:
“Ummm… did we run out of Dr’s, cops, addiction specialists or people who are actually dealing with this on the street to lead this?”
As a first responder, Synan is one of many people who are frustrated with the current actions being taken.
“I don’t want to get involved in politics, but it seems like it is a political position … I think I would have gone out to the country and tapped into people who are national experts who are on the street who are literally dealing with this issue every day,”
It seems many on the front lines are not impressed with the Trump administration’s move to put Kellyanne Conway in charge of efforts to combat one of the worst drug problems in the nation’s history.
Publicity and Perception
During a press briefing about the Justice Department’s efforts to combat the crisis where the announcement was made, Sessions said President Donald Trump chose Kellyanne Conway to “change the perception” about opioids and reduce addictions and deaths.
According to Sessions, President Trump has made the epidemic “a top priority for his administration, including every senior official and Cabinet member.”
An opioid policy expert Andrew Kolodny of Brandeis University actually defended the move when speaking to BuzzFeed News, stating:
“It is a positive sign. She is a high-profile figure in the administration, showing the administration takes this seriously,”
Some believe this can offer a sign of hope for more concrete action since many recovery advocates say despite the declaration of a public health emergency from President Trump there has been very little action taken to change the state of the epidemic.
Bertha Madras, a member of the President’s Commission on Combating Drug Addiction and the Opioid Crisis and Harvard Medical School professor, said:
“The most important thing that Kellyanne Conway will provide is access … but also commitment… She was at all the meetings, she listened and took copious notes.”
Let’s hope those are some good notes because thus far the opioid problem in America has shown no signs of slowing down. Jeff Sessions justified the appointment by saying Kellyanne Conway “understanding messaging” and can help turn around public perception. But is this about publicity, or is it about the preservation of life?
Surely breaking the stigma and changing the way addiction is viewed does matter, but should someone who specializes in making things look good to be in charge of how this country deals with one of the most prominent crises we face?
Treatment and Resources
Kellyanne does seem to support treatment, but to what extent it is still unclear. In one interview with ABC Kellyanne Conway did say,
“Pouring money into the problem is not the only answer. We have to get serious about in-facility treatment and recovery.”
So she at least appears to understand how crucial effective inpatient treatment is for recovery.
But when reporters mentioned the fact that there needs to be funding for these programs, she put more emphasis on “a 4 letter word called will” that seems to side-step the question- where will these resources come from?
As it now stands, White House has:
- Left the leadership role of the Office of National Drug Control Policy vacant
- Failed to release any written opioid-control strategy
- Not requested funds to replenish the national public health emergency fund that currently sits at just $66,000
In fact, President Trump’s 2018 budget request would increase addiction treatment funding by less than 2%. And don’t be fooled, that increase includes the $500 million already appropriated by Congress in 2016 under the 21st Century Cures Act with the Obama administration.
Even Chris Christie, the Republican New Jersey Governor who led the White House Opioid Commission, said:
“In New Jersey, we are spending $500 million,” he said. “I am not, quite frankly, impressed with $1 billion from the federal government for the nation.”
Strict Prevention and Punishment
When you look at what she has said on record in regards to opioids and addiction, it doesn’t really inspire a great deal of confidence. Kellyanne Conway has consistently hinted to an outdated ideology of what addiction is and how to address it.
In the past, Kellyanne has said,
“The best way to stop people dying from overdoses and drug abuse is by not starting in the first place… That’s a big core message for our youth.”
That’s right; just say no.
Critics say this aligns with the mindset of Jeff Sessions and others in the White House who seem to think that ‘Just Say No’ tactics actually work, or that purely prevention-based programs like D.A.R.E. can solve the whole problem. While prevention is important, it has proven to be ineffective as a focal point when addressing addiction.
Circling back to publicity, what Ms. Conway does seem to heavily endorse is a White House investigation for a “national ad campaign” on abuse prevention. President Trump himself had voiced his own support for a national advertising initiative to try and deter drug use.
But we all remember those commercials- this is your brain on drugs- and they didn’t really help that much.
Again, it seems Attorney General Sessions and the current administration is more focused on punishment than treatment and strict law enforcement. Sessions said the Justice Department was giving more than $12 million in grants to state and local law enforcement to help them prosecute crimes connected to:
Sessions is also ordering all U.S. Attorney offices to designate opioid coordinators. Kaitlyn Boecker, Policy Manager with the Drug Policy Alliance, has been vocal in her disapproval of the current steps being taken.
“Despite declaring the opioid overdose crisis a public health emergency just last month, the Trump Administration continues to emphasize failed prohibitionist policies while ignoring proven public health measures that we know reduce overdose death, like community naloxone distribution.”
“As we feared, the Administration is using the overdose crisis as an excuse to ratchet up the war on drugs rather than an opportunity to save lives.”
At this point, we can say that the news is not without skeptics. While many are still trying to remain hopeful that maybe because Kellyanne is so vocal and such a well-known surrogate for the president that perhaps she will be able to garner more attention to the issue.
While the fight for more resources continues, we should always encourage people to seek help. There are many safe and effective treatment resources already that have been helping people recover from drug and alcohol addiction for decades, like Palm Healthcare Company. If you or someone you love is struggling, please call toll-free now. We want to help.
CALL NOW 1-888-922-5398
If that headline seems kind of confusing, don’t worry, it should. Technically insurance companies are already required by law to provide the same coverage for substance abuse and mental health that they do for other health conditions… and therein lies the issue.
Back in August the White House Opioid Commission, established by President Trump and led by New Jersey Governor Chris Christie, made several recommendations to the current administration about how to address the current drug crisis as it damages communities across the country. One of those recommendations was to declare a national emergency, while others had to do with options for prevention and education.
In the aftermath of ex-DEA agent Joe Rannazzisi’s eye-opening interview exposing the shady connections between Congress and Big Pharma companies, many have been looking closely at how government officials and multi-billion dollar empires helped create the opioid epidemic. Now the White House’s Opioid Commission is putting a focus on how health insurance companies and the flaws in their policies have contributed to the intensifying addiction crisis.
So with the opioid commission saying they will call-out insurers and make demands on coverage for addiction treatment, will more people have access to help?
Restricted Addiction Treatment
One of the biggest issues the opioid commission seems to have with insurance companies is that frequently their policies only cover one type of addiction treatment and not others. It seems insurance companies are convinced that with a complex and extremely personal issue like substance use disorder or mental health conditions, there is a one-size-fits-all answer. Sadly, most advocates can tell you this isn’t the case.
Something else especially frustrating is that laws already exist to prevent insurers from treating addiction treatment different than any other health issue. Chris Christie himself said,
“Why are we still not seeing addiction services covered, and mental health services covered as broadly as every other type of disease?”
“And what do we need to do to make sure that the law is enforced and followed?”
The Mental Health Parity and Addiction Equity Act of 2008 requires health insurers to treat mental health and substance abuse disorders the same as any other disease. It means they should provide health care coverage for these conditions without additional limits, co-pays or deductibles. If companies add on additional requirements, it creates even more barriers between the suffering individual and treatment. Sadly, not every insurance company thinks it has to play by the rules.
A task force convened by President Barack Obama last year reported that numerous insurance companies still place a number of limits on addiction coverage, like more strict pre-authorization requirements. The insurance companies claim that their policies are only part of a complex problem, insisting that the issue also has to do with shortages of doctors and poor medical training from healthcare providers in the field of addiction treatment.
However, the simple fact that insurance companies are still trying to push back against supporting addiction treatment has the opioid commission ready to address the inconsistencies that are making it even harder for people who need help to get the help they deserve.
Holding Insurance Companies Accountable
The opioid commission is not holding back when it comes to trying to make insurance companies contribute to solutions since they helped contribute to the problem. The New Jersey Governor warned health insurance companies to be prepared for a final report that will “place new demands” on health insurance policies.
Christie and the opioid commission seem to be playing offense, saying Big Pharma drug companies and health insurers profit while allowing an epidemic of addiction to continue, but these new demands will hopefully change all that. Christie added,
“I’m a capitalist. I want everybody to make profits. I think it’s great. But we can’t any longer go about addressing this problem this way,”
“I hope you’re prepared to accept the challenge, because we know if it hasn’t gotten into your own house yet, it could, and then all the sudden your perspective on this problem could become markedly different.”
Not only is there more pressure on insurance companies when it comes to treatment options in their policies, but with how they handle medications in the first place.
Health insurance providers are also under a greater deal of scrutiny for policies that sometimes favor powerful and addictive painkillers over less addictive, and more expensive, variations. So not only are they limiting the options when it comes to getting treatment for substance abuse, but they are limiting coverage of medications to more addictive drugs to save money.
Insurance providers did show up to testify at the commission to help create a more comprehensive view of the issue. Involved were executives from some of the nation’s largest insurance companies:
- Blue Cross Blue Shield
- Harvard Pilgrim Health Care
- Kaiser Permanente
- UnitedHealth Group
- UPMC Health Plan
Representative Elijah Cummings, the ranking member of the House Oversight Committee, also has questions for many of those same companies. Some of these inquiries stem from a report by The New York Times last month stating insurance companies “erected more hurdles to approving addiction treatments than for the addictive substances themselves.”
Cummings wrote letters to seven of the companies which state,
“This is not a hypothetical problem. The over-prescription of opioids leads to addiction and death.”
The White House’s opioid commission has also spoken with leaders in the pharmaceutical industry. All this shows that the opioid commission is not only worried about exploring our options for fixing the issue but also in examining all the elements that helped cause the opioid epidemic in America. Christie says the final report to President Trump will include sweeping recommendations but will also be “extraordinarily instructive in terms of how we got here, which is an important thing for this commission to acknowledge.”
The commission will hold its last meeting November 1st before delivering its final report to the President. Only time will tell what demands this report plans to place on insurance companies to provide more coverage for addiction treatment services.
Will Insurance Companies Change?
The big question becomes how will this impact the services offered by insurance companies. Will the opioid commission’s suggestions help shape new policies, or will some insurance companies continue to ignore the parity laws put in place to make sure they do not discriminate against the treatment of substance abuse?
Will these changes allow for the coverage of different innovative and holistic treatment options, or will the change only support programs that depend on maintenance drugs like methadone or Suboxone?
Hopefully, the new demands being put on insurance companies will help to support mental health and substance abuse parity. When it comes to addressing addiction in America, we need every resource we can get in order to move forward with overcoming the opioid epidemic. With more officials taking a closer look at every aspect of the issue, perhaps we can get a more effective strategy for addressing the problem.
With so many people struggling with opioids and other drugs across the country, comprehensive and effective treatment is essential to making any real progress. For decades Palm Healthcare Company facilities have been providing holistic addiction treatment options that help create lasting change. If you or someone you love is struggling with substance abuse or addiction, please call toll free now.
CALL NOW 1-888-922-5398
Drug overdoses killed 64,000 Americans last year. That is an increase of more than 20% than the overdose deaths in 2015. Those numbers have nearly quadrupled since 2000. Now nearly two-thirds of overdose deaths are from by opioids. Some are from prescription opioids; others are from illicit heroin or synthetics like fentanyl.
However, some are concerned that the action we have seen thus far is too little too late. The president’s 2018 budget only increases addiction treatment funding by less than 2%. That already includes the $500 million appropriated by Congress in 2016 under the 21st Century Cures Act. So needless to say, many recovery advocates worry that the resources are just not going to be enough.
If we look at the recommendations of the president’s opioid commission, and at other initiatives that have started to gain some traction across the country, we can find patterns. There are some concepts that consistently show up, and perhaps if we focus on these similarities, we can see why so many minds are thinking alike.
So here are 5 big ways America can overcome the opioid epidemic.
Break the Stigma
In order to accomplish most of the things on this list, America first has to consistently fight to break the stigma of drug use and addiction. Misunderstanding what addiction is and how it happens only undermines progress to addressing it. If America hopes to overcome the opioid crisis, we have to be more willing to see it for what it is.
Right now the issue of addiction stigma is still a big deal. While we may have come a long way from how it was decades ago, there are still a lot of people who refuse to consider addiction as an illness. A lot of people still refuse to acknowledge the various factors that contribute to addiction, such as genetic predisposition and instead insist addiction is purely by choice.
If we can see how drug use affects people from all different walks of life, and for countless different reasons, we can then treat those suffering from more compassion. Finding more effective methods of treatment means having a better idea of what really causes addiction, and what feeds it.
Support PAARI, NOT Punishment
Speaking of compassion, supporting PAARI and not punishment is a perfect example of letting go of stigma to work toward saving lives.
It is about time that all of America realizes that the old ways of the failed War on Drugs do not work. Thankfully, it seems a lot more people across the country now understand that we cannot arrest our way out of this problem. Harsher punishments and severe sentences have not deterred addiction, they only support stigma.
Now in America, there are nearly 300 law enforcement agencies across 31 states that have Police Assisted Addiction and Recovery Initiative programs (PAARI). These PAARI programs offer treatment for drug users who come to authorities looking for a way out. Instead of fearing the threat of arrest, people struggling with substances are encouraged to reach out to law enforcement in order to be put in contact with treatment options or recovery networks.
This revolutionary new mindset was inspired by a department in Gloucester, Massachusetts not too long ago. So far these efforts appear to cost much less and with better results than efforts focused on punishing addicts.
Create Resources for Treatment
Today addiction medicine is an urgently needed specialty, but there is not much glory in it compared to other areas of medical work. One way the federal government could help create more resources for treatment is to provide tuition incentives for medical students to enter addiction-related specialties and work in underserved communities. By encouraging this kind of work, we further shed the stigma of addiction and shift the perspective to helping care for a vulnerable community.
But don’t just end with specialists.
By supporting things like Medicaid expansion, addiction and mental health treatment can be made available to more people who may not have access to healthcare under limited coverage. More state and federal funding can also be allocated by officials to help build or strengthen addiction treatment programs provided by the state.
Enforce Mental Health Parity
The Mental Health Parity and Addiction Equity Act of 2008 actually requires insurers provide equal benefits for mental health and addiction treatment that they do with other medical therapies or surgery. Thus, the law means to make discrimination against addicts by insurers illegal.
However, some insurers defy this law by imposing illogical treatment limits or tedious authorization requirements. In other words, insurance companies are finding ways to cheat the system in order to avoid paying for addiction and mental health treatment.
America and our government must to better to enforce mental health parity. If we want people to get the treatment they need, we have to protect their right to treatment and assure that insurance providers won’t be able to skip out on the bill.
According to John Renner, president of the American Academy of Addiction Psychiatry, between 50%- 70% of people with substance abuse problems also suffer from a mental health disorder such as:
- Post-traumatic stress disorder (PTSD)
With mental health and addiction so closely related, making sure those struggling with opioids and other substances receive care for mental health disorders or other co-occurring conditions it vital to lasting recovery.
First and foremost; preserve life! This should always be a priority when facing any kind of epidemic. Regardless of the circumstances, the preservation of life should always be paramount. This is a discussion that has become crucial in the fight against opioids considering the need for life-saving medications and harm reduction tactics.
At the moment, first responders and emergency rooms do not have adequate access to Naloxone or Narcan, the opioid overdose antidote, to save lives. Both federal and state health agencies can negotiate pricing for naloxone and expand access. They can also encourage pharmacies that offer prescription-free access in some areas.
Another aspect of saving lives involves harm reduction strategies, which tend to be a little more controversial. Not everyone likes to support programs like safe injection sites or needle exchange programs. However, whether you think these programs enable addiction or not, these programs are proven to help preserve life. Between preventing the spread of infectious disease and providing a supported environment in case of overdose, these harm reduction models can prevent a lot of needless loss of life.
One indisputable precedence in the effort to overcome opioids is keeping people suffering alive long enough to get them treatment. The more people we can help survive opioid addiction, the more people have a chance of recovering.
Drug abuse and addiction is a devastating and deadly disease, and providing effective and compassionate treatment makes a lifelong difference. Part of solving the problem is changing the way we look at it and changing how we treat each other. If you or someone you love is struggling with substance abuse or addiction, please call toll-free now.
CALL NOW 1-888-922-5398
If you think heroin is the deadliest opioid in America, think again. While that might have been the case in the past, things have taken a major shift over the past few years.
Heroin led to nearly 16,000 deaths last year, but another popular opioid surpassed that tragic number.
If you have not guessed already, we are talking about fentanyl.
Fentanyl is an opioid that is over a 100 times stronger than street heroin. To put that into perspective, transdermal fentanyl is 100-150xs more potent than oral morphine and is often prescribed to treat advanced cancer patients.
Drug overdose deaths involving fentanyl doubled during 2016, accounting for 25% more deaths than heroin, according to data released by the Centers for Disease Control and Prevention (CDC) earlier this week.
In 2016, the data revealed that 64,000 Americans died of drug overdoses. Out of this number, 20,100 deaths were attributed to fentanyl and other synthetic opioids. If we compared those numbers to heroin deaths, that’s an almost 5000 person difference!
The recent data also reveals how unevenly drug deaths are spread throughout the country:
- In states like Delaware, overdose rates rose 71% between 2016 and 2017 (with 309 deaths during the year).
- Maryland had an increase of 67% for a total of 2,171 overdose deaths.
- Of the states that reported data, only Nebraska, Washington and Wyoming saw a decrease in overdose deaths over the past year.
Fentanyl has been getting a great deal of attention as the drug is responsible for the massive increase in overdose fatalities. For example, last year in Massachusetts, 69% of people who died of an opioid overdose (and had a toxicology screen) had fentanyl in their systems, according to the Boston Business Journal.
Furthermore, in Ohio, fentanyl killed nearly 2,400 people in 2016, which is double the number in comparison to the year prior, according to Cincinatti.com
“It truly is everywhere,” Barbara Carreno, a spokeswoman for the federal Drug Enforcement Agency (DEA), said to USA Today.
Education is Key
Over the summer, the DEA worked to educate first responders about the dangers of fentanyl and other synthetic opioids like carfentanil and acryl fentanyl. These synthetic opioids are strong enough to make even the most casual user overdose and pose a severe threat.
Despite the dangers of addicts receiving a potentially fatal drug, law enforcement officials say the demand for fentanyl continues to rise. This is because fentanyl boost profits for dealers to sell the drug as heroin.
“You can make it as strong as you want, and in bulk and fast,” said Tim Reagan, a DEA agent in Cincinnati.
Still, law enforcement expects fentanyl seizure to become more of the norm at the end of this year.
“I expect that in fiscal year 2017, the numbers of seizures in the mail and express consignment environment (such as FedEx and UPS) will be much higher than they were last year,” said Robert Perez, an acting commissioner with the U.S. Customs and Border Protection (CBP) agency.
Where is it coming from?
Fentanyl is coming from a variety of locations, but one main target is China. China has been singled out as the main source of synthetic opioids like fentanyl. Through the dark web, drug dealers are able to purchase fentanyl from websites hosted in China. They then have shipments sent to the US.
According to the US Customs and Border Protection (CBP), seizures of fentanyl arriving by mail have increased significantly:
- In 2011, 0.09 kilograms of fentanyl were seized by mail
- In 2016 it rose to 37 kilograms
Unfortunately, officials in the United States are expecting the worse when it comes to the opioid crisis. Experts are looking at current trends, and most believe the opioid crisis will get worse before it gets better.
Did you know the major impact fentanyl was having on the opioid crisis? Sadly, when it comes to using drugs, your next high could be your last. Therefore, make a choice to recover from addiction today. Tomorrow may be too late. Do not wait. We are waiting for your call. Call now.
CALL NOW 1-888-922-5398